LivaNova closes $225M buyout of ImThera Medical
LivaNova closed the $225 million acquisition of ImThera Medical, which makes the Aura6000 implantable hypoglossal nerve stimulator for sleep apnea. LivaNova paid $78 million upfront, with $147 million due on milestones.
ProductsAura6000 implantable hypoglossal nerve stimulator for sleep apnea
“LivaNova closed the $225 million buyout of ImThera Medical and its implantable sleep apnea treatment.”massdevice.com
- 5 sources
- massdevice.comUPDATE: LivaNova closes $225m ImThera buyout - MassDeviceBrad PerrielloJan 23, 2018
- dicardiology.comLivaNova Enters Binding Letter of Intent to Sell Cardiac Rhythm Management Business | DAICJan 26, 2018
- investor.livanova.comLivaNova to Acquire TandemLife | LivaNova PLCFeb 14, 2018
- crtonline.orgLivaNova to acquire TandemLife - CRTonline<p>CRTonline.org</p>Feb 15, 2018
- medicaldevice-network.comM&As this week: Johnson & Johnson, LivaNova, LGC Limited - Medical Device NetworksmadhukarFeb 23, 2018
Summarized from public sources; check the original articles before acting on it.
ENDATA